Skip to main content
OpenTrials
Completed

NCT Number: NCT02272426

The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke

It is estimated that 2 out of 3 patients with a stroke have some problems with their memory, difficulties performing certain tasks, making decisions and learning new things. In addition, many stroke patients do not get regular exercise and are often sedentary. Both physical and cognitive exercise have the potential to improve quality of life, cognition, and overall health, but the safety and tolerability of such interventions is not clear in stroke patients. The investigators will examine these outcomes by allocating stroke survivor participants to one of two groups: a combined exercise and cognitive training program and a sham control group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jackson Memorial Hospital, Miami, Florida, United States

Loading trial locations.

About this study

Stroke is well recognized as the leading cause of disability in the United States. Cognitive deficits after stroke are common, even in those without dementia prior to the event, and stroke patients with worse cognition on hospital admission have worse outcomes. Cognitive deficits contribute to stroke-related disability and mortality. Evidence suggests an interaction between cognitive deficits and physical limitations, and cognitive rehabilitation may improve functional outcomes post stroke. Recent data also suggest that both cognitive training and exercise interventions improve cognition in stroke patients, but few randomized trials of these interventions, alone or in combination, have been conducted.

We will study the effects of a Combined Aerobic and Resistance Exercise Training (CARET) program and CTI interventions on the primary outcome of safety, feasibility, and adherence among ischemic or hemorrhagic stroke survivors with mild to moderate disability. We hypothesize that these interventions are safe and tolerable, and that they will lead to improvements in our secondary outcomes of cognitive performance and quality of life. We will also explore the role of Brain Derived Neurotrophic Factor in cognitive changes related to the physical exercise intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of ischemic or hemorrhagic stroke
  • Modified Rankin Score (mRS) of <4 at screening
  • Recently discharged from the hospital or rehabilitation program
  • Male or female ≥18 years of age
  • Less than ideal physical activity ≥ 3 months prior to enrollment (less than ideal physical (as defined by the American Heart Association)
  • Able to walk ≥10 meters with or without assistance

Exclusion criteria

  • Unable to follow instructions for exercise and cognitive interventions
  • Any uncontrolled medical condition expected to limit life expectancy or interfere with participation in the trial (i.e. unstable cancer, severe depression or anxiety by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria)
  • Abnormal stress test, as determined by the treating physician (unless cardiology clearance provided)
  • Active substance abuse or alcohol dependence
  • Less than 6th grade reading level
  • Uncorrected vision or hearing deficits that would preclude administration of the cognitive measures
  • Unwilling or unable to provide written informed consent

Treatment and study plan

CARET

Behavioral

Combined Aerobic and Resistance Exercise Training

CTI

Behavioral

Cognitive Training Intervention

Sham CARET

Behavioral

Sham Combined Aerobic and Resistance Exercise Training

Sham CTI

Behavioral

Sham Cognitive Training Intervention

Primary outcomes

  1. Number of participants with treatment emergent serious adverse events

    Time frame: At 12 weeks visit (post-intervention)

    To assess the number of participants with serious adverse events related to the interventions, comparing active groups versus the sham group.

  2. Adherence to a 12-week combined exercise and cognitive training protocol versus a sham group

    Time frame: At 12 weeks visit (post-intervention)

    To assess participant adherence in the intervention group versus the sham group, comparing time on study.

Secondary outcomes

  1. Change in Cognitive Performance on cognitive neuropsychological battery done at pre, post and 6 month follow-up visits

    Time frame: Baseline to 6 months follow up

    Global cognitive performance will be compared for the intervention groups versus the sham group, using a cognitive assessment battery.

  2. Change in Health Related Quality of Life - Depression

    Time frame: Baseline to 6 months follow up measure.

    As measured by Center for Epidemiologic Studies Depression Scale (CES-D). Minimum score 0, maximum score 60, and a score of 16 or higher indicates clinical depression.

  3. Change in Health Related Quality of Life - Daily Activities

    Time frame: Baseline to 6 months follow up

    As measured by Stroke impact scale scores measuring health related quality of life. Minimum score 16, maximum score 80. Higher scores indicate higher level of functionality in participants, while lower scores indicate a lower level of functionality.

  4. Change in blood plasma concentration of Brain Derived Neurotrophic Factor

    Time frame: Baseline to 6 month follow up

    Brain-derived neurotrophic factor (BDNF) levels will be compared between the exercise group and the sham group at baseline and 12 weeks.

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Collaborators

  • American Heart Association
  • Bugher Foundation

Registry information

Important dates

Study start
2014
Primary completion
2019
Study completion
2019
First posted
Oct 23, 2014
Registry last updated
Jun 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.